Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

• Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? via openalex
• Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive via openalex
• Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive via openalex
• Progestins and Antiprogestins in Clinical Practice via openalex
• W1488133193 via openalex
• W1776852909 via openalex
• doi:10.1016/s0010-7824(02)00436-5 via openalex
• doi:10.1016/0010-7824(90)90034-s via openalex
• doi:10.1111/j.1538-7836.2010.04148.x via openalex
• doi:10.1016/s0140-6736(95)91929-5 via openalex
• doi:10.1016/s0140-6736(95)91928-7 via openalex
• doi:10.1111/jth.12054 via openalex
• doi:10.1046/j.1365-2141.2003.04443.x via openalex
• doi:10.1136/bmj.b2921 via openalex
• doi:10.1016/s0140-6736(95)91927-9 via openalex
• W4301096458 via openalex
• W6676115632 via openalex
• doi:10.1136/bmj.d2151 via openalex
• doi:10.1016/s0140-6736(99)06092-4 via openalex
• doi:10.1093/humrep/deh612 via openalex
• doi:10.1016/0010-7824(95)00098-u via openalex
• doi:10.1016/j.contraception.2008.11.002 via openalex
• doi:10.1177/0091270006297919 via openalex
• doi:10.1056/nejm200105173442007 via openalex
• doi:10.1111/j.1538-7836.2012.04720.x via openalex
• doi:10.1055/s-0037-1613960 via openalex
• doi:10.1016/j.contraception.2008.04.004 via openalex
• doi:10.1160/th07-07-0439 via openalex
• doi:10.1016/s0010-7824(00)00196-7 via openalex
• doi:10.1111/j.1538-7836.2004.00983.x via openalex
• doi:10.1046/j.1538-7836.2003.00264.x via openalex
• doi:10.1136/bmj.d2139 via openalex
• doi:10.1136/bmj.b2890 via openalex

Cited by (7)

• Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis 2022
• Overview of the therapeutic possibilities of combined oral contraceptive containing estradiol valerate and dienogest 2019
• Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives? 2018
• Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age 2018
• Metabolic impact of combined hormonal contraceptives containing estradiol 2016
• The influence of oral combined oral contraceptive with estradiol valerate and dienogest  on hemostatic system (a review) 2015
• Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature 2014

Source provenance

openalex

last seen: 2026-05-11T06:37:04.871248+00:00